⌚ Can a smartwatch identify high-risk patients after discharge?
In STEP-CANCER, ≤3,013 steps/day was linked to 90-day readmission (73% vs 13%) and mortality (47% vs 9%).
Congrats to @drOrhunakdogan , @uyargalip and team. Special thanks to @crisbergerot and @realbowtiedoc 🙏
In STEP-CANCER, ≤3,013 steps/day was linked to 90-day readmission (73% vs 13%) and mortality (47% vs 9%).
Congrats to @drOrhunakdogan , @uyargalip and team. Special thanks to @crisbergerot and @realbowtiedoc 🙏
Published! 🚀 Can wearables predict post-discharge risk in metastatic cancer? ⌚
Lower post-discharge mobility was associated with higher 90-day readmission & mortality.
Co-first w/ @drOrhunakdogan, with @crisbergerot @Realbowtiedoc @osutcuoglu @kbaskurtt @tubaugurdr @Xesiloglu
#DigitalOncology #Wearables #CancerCare #MedX #SupportiveCare
@ASCO @myESMO @oncodaily @OncoAlert @SuppCareCancer
doi.org/10.1007/s00520…View quoted post on X
